N(alpha)-fmoc-N(in)-boc-L-tryptophan CAS:143824-78-6
N(alpha)-fmoc-N(in)-boc-L-tryptophan chinhu chakakosha mukugadzirwa kwepeptide, kunyanya mukudzivirira boka reamino re tryptophan residues. Iyi compound inogonesa kuumbwa kwepeptide bond inodzorwa uye yakasarudzwa, ichibatsira mukugadzirwa kwe peptide structures dzakaoma dzine ma sequences chaiwo akakosha kune akasiyana mashandisirwo mu biochemistry, chemical biology, uye pharmaceutical development. Kushandiswa kwayo kunosvika pakugadzirwa kwe peptide-based pharmaceuticals, uko kugadzirisa kwakanyatsorongeka kwakakosha pakuwedzera kushanda kwekurapa uye kusiyanisa. Pamusoro pezvo, inobatsira kukura kwe peptide mimetics uye modified protein structures dzinoshandiswa mukutsvaga mishonga, zvidzidzo zve biochemical, uye kutsvagisa kwe biomedical. Uyezve, iyi compound inoita basa guru mukuvaka peptide derivatives uye conjugates, nokudaro ichibatsira mukufambira mberi mu chemistry biology, biotechnology, uye medical chemistry. Kukosha kwayo mukuita kuti controlled peptide synthesis isimbise basa rayo guru mukubatsira kugadzirwa kwe peptides nemaproteins ane hunhu hwakagadzirirwa hunoenderana nemashandisirwo akasiyana esainzi nemaindasitiri. Nekuda kweizvozvo, N(alpha)-fmoc-N(in)-boc-L-tryptophan inoshanda sechishandiso chakakosha kune vaongorori nevashandi vanoshanda muminda yakaita semishonga, biochemistry, biotechnology, uye makemikari, zvichiratidza kukanganisa kwayo kukuru pakutsvaga kwakasiyana-siyana uye mabasa emaindasitiri.
| Kuumbwa | C31H30N2O6 |
| Kuyedza | 99% |
| Chitarisiko | upfu chena |
| Nhamba yeCAS | 143824-78-6 |
| Kurongedza | Diki uye rakakura |
| Hupenyu hweSherufu | makore maviri |
| Kuchengetera | Chengeta munzvimbo inotonhorera uye yakaoma |
| Chitupa | ISO. |








